AIkido Pharma Inc logo

AIkido Pharma Inc

$ 3.90 -0.0201 (-0.51%) 10:08 PM EST
P/E:
At Loss
P/B:
0.24
Market Cap:
$ 21.39M
Enterprise V:
$ -20.43M
Volume:
25.67K
Avg Vol (2M):
37.78K
Also Trade In:
Volume:
25.67K
Market Cap $:
21.39M
PE Ratio:
At Loss
Avg Vol (2-Month):
37.78K
Enterprise Value $:
-20.43M
PB Ratio:
0.24
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.
Name Current Vs Industry Vs History
Cash-To-Debt 57.28
Equity-to-Asset 0.97
Debt-to-Equity 0.01
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -3.53
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 8.34
9-Day RSI 11.99
14-Day RSI 17.04
6-1 Month Momentum % 21.64
12-1 Month Momentum % -51.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 29.54
Quick Ratio 29.54
Cash Ratio 22.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -254.7

Financials (Next Earnings Date:2023-02-10 Est.)

AIKI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AIKI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.93
Beta 0.99
Volatility % 48.87
14-Day RSI 17.04
14-Day ATR ($) 0.280403
20-Day SMA ($) 4.795745
12-1 Month Momentum % -51.74
52-Week Range ($) 3.8142 - 12.9166
Shares Outstanding (Mil) 5.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AIkido Pharma Inc Filings

Document Form Filing Date
No Filing Data

AIkido Pharma Inc Analysis

Share your research

Headlines

See More
No news.